We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

138 hedge funds and large institutions have $290M invested in Viking Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 45 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $3.5M

57% more capital invested

Capital invested by funds: $184M → $290M (+$106M)

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

1.17% more ownership

Funds ownership: 54.25% → 55.42% (+1.2%)

1% more funds holding

Funds holding: 137 → 138 (+1)

4% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 45

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
45
Closed
18
Calls
$13.7M
Puts
$3.5M
Net Calls
+$10.2M
Net Calls Change
+$5.4M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$4.22M
2
Northern Trust
Northern Trust
Illinois
+$4.15M
3
Goldman Sachs
Goldman Sachs
New York
+$3.27M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.07M
5
Millennium Management
Millennium Management
New York
+$2.35M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$2.56M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$2.4M
3
Aviva
Aviva
United Kingdom
-$1.86M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.84M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.65M

VKTX Hedge Fund Activity: Q2 2020 in Review

138 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q2 2020, worth a combined $290M — up 57% from $184M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VKTX positions and 18 closed out — a net gain of 2 holders — while 43 added to existing stakes and 45 trimmed.

The largest buyer was State Street, adding an estimated $4.22M. The largest seller was Sphera Funds Management, cutting an estimated $2.56M.

  • 138 institutional investors held Viking Therapeutics (VKTX) as of Q2 2020, up from 137 in Q1 2020.
  • Funds reported $290M of Viking Therapeutics stock for Q2 2020, up 57% quarter-over-quarter.
  • 20 funds opened new Viking Therapeutics positions in Q2 2020 and 18 closed out, a net change of +2 holders.
  • The largest Viking Therapeutics buyer in Q2 2020 was State Street, an estimated $4.22M added.
  • The largest Viking Therapeutics seller in Q2 2020 was Sphera Funds Management, an estimated $2.56M sold.

Based on aggregated 13F filings for Q2 2020.